Fusion Scans
Back

BBIO

NASDAQ
BridgeBio Pharma, Inc. · Healthcare · Biotechnology
Loading quote…

Highlights

Market Cap
$12.95B
PE Ratio
EV to Ebitda
Earnings Yield
-5.32%
Revenue (TTM)
$502.1M
Net Income (TTM)
$-732.9M
Revenue (Annual YoY Growth)
126.26%
Revenue (Quarterly YoY Growth)
2521.18%
Profit Margin
-145.98%
Return on Equity
Debt to Equity Ratio
-1.3077
Dividend Yield
0.00%

All fundamentals

Core10 fields
Market Cap$12.95B
Revenue TTM$502.1M
Shares Outstanding193.9M
Float138833331
Float Short14.04%
Days To Cover10.5208011481
Short Interest22579883.0
Insider Ownership53.23%
Relative Strength47.7
GARP3475
Growth Estimates14 fields
Revenue Growth (Annual)126.26%
Revenue Growth (Quarterly YoY)2521.18%
Operating Revenue Growth (Annual)0.404794
Operating Revenue Growth (Quarterly YoY)0.47099
3-Year Revenue Growth86.30%
5-Year Revenue Growth127.44%
EPS Growth (Annual)-31.46%
EPS Growth (Quarterly YoY)28.78%
3-Year EPS Growth Rate0.00%
5-Year EPS Growth Rate0.00%
EBITDA Growth (Annual)13.07%
EBITDA Growth (Quarterly YoY)42.27%
CFO Growth (Annual)14.37%
CFO Growth (Quarterly YoY)71.11%
Operations28 fields
Revenue TTM$502.1M
Gross Margin TTM95.28%
Gross Margin (Quarterly)94.27%
R&D % of Revenue TTM90.02%
R&D Expenses TTM$452.0M
Operating Margin TTM-100.00%
Operating Margin (Quarterly)-83.30%
Operating Expenses TTM$980.4M
Profit Margin TTM-145.98%
Profit Margin (Quarterly)-126.24%
Net Income TTM$-732.9M
EPS TTM-3.7842
EPS (Quarterly)-0.9964
EBIT Margin TTM-100.00%
EBIT Margin (Quarterly)-83.30%
EBITDA Margin TTM-98.92%
EBITDA Margin (Quarterly)-82.37%
EBITDA TTM$-496.6M
CFO % of Revenue TTM-88.81%
CFO % of Revenue (Quarterly)-36.59%
CFO TTM$-445.9M
Cash Margin-89.37%
Capex % of Revenue TTM1.91%
Capital Expenditures$9.6M
FCF % of Revenue TTM-90.72%
FCF % of Revenue (Quarterly)-36.62%
FCF TTM$-455.5M
Fundamental Score4
Efficiency5 fields
ROA-76.10%
ROIC-96.35%
CROCI-59.88%
Stock Comp % (Quarterly)22.47%
Stock Comp % TTM26.49%
Valuation12 fields
P/S Forward15.0982
PEG-0.5712
EV/EBITDA Forward-48.6944
EV/Revenues (TTM)31.7408
EV/Revenues Forward17.4536
EV/CFO-38.2338
EV/FCF (TTM)-34.9863
Price to Tangible Book-1.049
Earnings Yield-5.32%
FCF Yield-3.34%
Dividend Yield0.00%
Value Score1
Relative to Industry3 fields
Relative Gross Margin (Quarterly)1.2077
Relative P/S4.4219
Relative Dividend Yield0
Liquidity15 fields
Cash Per Share3.0191
Current Ratio2.7702
Cash & ST Assets$588.0M
Total Debt$2.71B
Goodwill & Intangibles$28.1M
Total Assets$936.0M
Total Liabilities$3.01B
Shareholders Equity$-2.09B
Debt to Equity-1.3077
Debt to Assets291.52%
Interest Expense$141.8M
Times Interest Earned-3.5399
CFO to Debt (TTM)-0.1759
Debt to EBITDA (TTM)-5.1054
Goodwill % of Assets3.00%
Yields4 fields
Dividend Yield0.00%
Earnings Yield-5.32%
Buyback Yield0.10%
Shareholder Yield-1.25%
Options Flow8 fields
Call Volume798
Put Volume195
Put/Call Ratio0.24436090225563908
Call $ Volume482510
Put $ Volume76611
Put/Call $ Ratio0.15877598391743175
Call OI33937
Put OI29951

News AI summary

Past 90 days of news, summarised by GPT

Upgrade to use
Click Generate to run a GPT analysis. Cached for 24h once generated.

Press release AI summary

Past 90 days of press releases, summarised by GPT

Upgrade to use
Click Generate to run a GPT analysis. Cached for 24h once generated.

Income statement AI analysis

Recent quarterly income statements with margin trends

Upgrade to use
Click Generate to run a GPT analysis. Cached for 24h once generated.

Balance sheet AI analysis

Recent quarterly balance sheets with leverage trends

Upgrade to use
Click Generate to run a GPT analysis. Cached for 24h once generated.

Cash flow AI analysis

Recent quarterly cash flow statements with FCF trends

Upgrade to use
Click Generate to run a GPT analysis. Cached for 24h once generated.